Related Experiment Video
Updated: Aug 16, 2026

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
Prion generation in vitro: amyloid of Ure2p is infectious
Andreas Brachmann1, Ulrich Baxa, Reed Brendon Wickner
1Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892-0830, USA.
Abstract:
[URE3] is a prion (infectious protein) of the Ure2 protein of yeast. In vitro, Ure2p can form amyloid filaments, but direct evidence that these filaments constitute the infectious form is still missing. Here we demonstrate that recombinant Ure2p converted into amyloid can infect yeast cells lacking the prion. Infection produced a variety of [URE3] variants. Extracts of [URE3] strains, as well as amyloid of Ure2p formed in an extract-primed reaction could transmit to uninfected cells the [URE3] variant present in the cells from which the extracts were made. Infectivity and determinant of [URE3] variants resided within the N-terminal 65 amino acids of Ure2p. Notably, we could show that amyloid filaments of recombinant Ure2p are nearly as infectious per mass of Ure2p as extracts of [URE3] strains. Sizing experiments indicated that infectious particles in vitro and in vivo were >20 nm in diameter, suggesting that they were amyloid filaments and not smaller oligomeric structures. Our data indicate that there is no substantial difference between filaments formed in vivo and in vitro.
Insights
Yeast prion [URE3], caused by Ure2 protein, is infectious. Amyloid filaments of recombinant Ure2p are nearly as infectious as cell extracts, confirming their role in prion propagation.
Area of Science:
- Biochemistry
- Molecular Biology
- Yeast Genetics
Background:
- The prion [URE3] in yeast is associated with the Ure2 protein, but direct evidence linking in vitro formed amyloid filaments to infectivity is lacking.
- Understanding the structural basis of prion infectivity is crucial for deciphering protein misfolding diseases.
Purpose of the Study:
- To investigate whether amyloid filaments of recombinant Ure2p can infect yeast cells and serve as the infectious form of the [URE3] prion.
- To characterize the infectious properties and structural determinants of the [URE3] prion.
Main Methods:
- Recombinant Ure2 protein was converted into amyloid filaments in vitro.
- These amyloid filaments were used to infect yeast cells lacking the prion.
- Infectivity was assessed by transmission to uninfected cells and characterization of [URE3] variants.
- Size exclusion chromatography and other methods were used to determine the size of infectious particles.
Main Results:
- Recombinant Ure2p amyloid successfully infected yeast cells, producing various [URE3] variants.
- Amyloid filaments of Ure2p showed infectivity comparable to cell extracts on a mass basis.
- The N-terminal 65 amino acids of Ure2p were identified as the determinant of infectivity and [URE3] variants.
- Infectious particles in vitro and in vivo were consistently larger than 20 nm, consistent with amyloid filaments.
Conclusions:
- Amyloid filaments of recombinant Ure2p are the infectious form of the [URE3] prion.
- There is no significant difference between Ure2p amyloid filaments formed in vivo and in vitro.
- The N-terminal region of Ure2p is critical for [URE3] prion infectivity.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents

